News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Martina Sluga-O’Callaghan

Articles by Martina Sluga-O’Callaghan

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
April 18th 2022

Trending on CancerNetwork

Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer

Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer

Prophylactic Cranial Irradiation Improves Survival in Limited-Stage SCLC

How Effective is Fixed-Duration Cevostamab in Multiple Myeloma?

Fixed-Duration Cevostamab Yields Durable Responses Off Therapy